Szot Matthew K sold CVKD
October 27, 2025 · Form 4 insider transaction
Szot Matthew K sold 1,800 shares of Cadrenal Therapeutics, Inc. at $13.99 per share, a transaction worth $25.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,800
Price
$13.99
Total value
$25.2K
InsiderSzot Matthew K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 27, 2025
Filing dateOctober 28, 2025
Shares owned after9,933
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025.